Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pilogel 4% eye gel
1106000X0BFAABD
|
Pilogel | Pilocarpine hydrochloride | Eye | No data available |
|
Polihexanide 0.02% eye drops
1103010AJAAABAB
|
Polihexanide (Eye) | Polihexanide | Eye | No data available |
|
Polihexanide 0.06% eye drops preservative free
1103010AJAAAAAA
|
Polihexanide (Eye) | Polihexanide | Eye | No data available |
|
Polihexanide 0.08% eye drops preservative free
1103010AJAAADAD
|
Polihexanide (Eye) | Polihexanide | Eye | No data available |
|
Polyfax ophthalmic ointment
1103010Q0BBAAAA
|
Polyfax (Eye) | Polymyxin B sulphate | Eye | No data available |
|
Polymyxin B 10,000units/g / Bacitracin 500units/g eye oint
1103010Q0AAAAAA
|
Generic eye ointment | Polymyxin B sulphate | Eye | No data available |
|
Polymyxin B 10,000units/g / Trimethoprim 5mg/g eye ointment
1103010Q0AAACAC
|
Generic eye ointment | Polymyxin B sulphate | Eye | No data available |
|
Polymyxin B 10,000units/ml / Trimethoprim 1mg/ml eye drops
1103010Q0AAABAB
|
Generic eye ointment | Polymyxin B sulphate | Eye | No data available |
|
Polytrim eye drops
1103010Q0BCAAAB
|
Polytrim | Polymyxin B sulphate | Eye | No data available |
|
Polytrim ophthalmic ointment
1103010Q0BCABAC
|
Polytrim | Polymyxin B sulphate | Eye | No data available |
|
Polyvinyl alcohol 1.4% eye drops
1108010Q0AAAAAA
|
Polyvinyl alcohol | Polyvinyl alcohol | Eye | No data available |
|
Polyvinyl alcohol 1.4% eye drops 0.4ml unit dose pf
1108010Q0AAACAC
|
Polyvinyl alcohol | Polyvinyl alcohol | Eye | No data available |
|
Polyvinyl alcohol 1% eye drops
1108010Q0AAABAB
|
Polyvinyl alcohol | Polyvinyl alcohol | Eye | No data available |
|
Povidone K25 5% eye drops 0.4ml unit dose preservative free
1108010T0AAAAAA
|
Povidone K 25 | Povidone K 25 | Eye | No data available |
|
Povidone-Iodine 5% eye drops preservative free
1108020AHAAAAAA
|
Povidone-Iodine (Eye) | Povidone iodine | Eye | No data available |
|
Prednisolone sodium phosphate 0.003% eye drops
1104010S0AAALAL
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.005% eye drops
1104010S0AABCBC
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.01% eye dps preserv free
1104010S0AAAZAZ
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.01% eye drops
1104010S0AAAAAA
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.025% eye dps preserv free
1104010S0AABJBJ
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.025% eye drops
1104010S0AAASAS
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.1% ear drops
1104010S0AABHBH
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.125% eye dps preserv free
1104010S0AAAXAX
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.125% eye drops
1104010S0AAAEAE
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
|
Prednisolone sodium phosphate 0.13% eye drops
1104010S0AAAQAQ
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.